FDA allows standalone use of nasal spray antidepressant Spravato (esketamine) : Shots
Spravato, the brand name for esketamine, has a newly approved indication for treatment-resistant depression. tadamichi/Getty Images/iStockphoto/iStockphoto hide caption…